Hang Lung Properties Limited (HLPPY)

Intra-Cellular Therapies Cash Flow Statement

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-	2,153	3,970	3,836	3,868	-2,571
Depreciation & Amortization	-	117	88	78	61	48
Gain (Loss) on Sale of Assets	-	-17	1	4	-16	-1
Asset Writedown	-	937	9	345	-460	6,664
Stock-Based Compensation	-	74	83	88	66	55
Income (Loss) on Equity Investments	-	-28	-38	-24	-9	88
Change in Accounts Receivable	-	221	60	-252	-243	-1,218
Change in Other Net Operating Assets	-	-389	588	-23	908	257
Other Operating Activities	-	1,729	1,524	1,104	1,965	409
Operating Cash Flow	-	4,956	3,712	4,139	2,732	3,413
Operating Cash Flow Growth	-	33.51%	-10.32%	51.50%	-19.95%	-35.83%
Acquisition of Real Estate Assets	-	-3,252	-3,080	-2,699	-2,855	-3,107
Sale of Real Estate Assets	-	23	19	15	139	6
Net Sale / Acq. of Real Estate Assets	-	-3,229	-3,061	-2,684	-2,716	-3,101
Investment in Marketable & Equity Securities	-	-24	-	41	1,176	716
Other Investing Activities	-	80	121	87	116	189
Investing Cash Flow	-	-3,173	-2,940	-2,556	-1,424	-2,196
Long-Term Debt Issued	-	44,599	44,273	34,860	25,402	17,861
Long-Term Debt Repaid	-	-37,664	-38,983	-33,994	-18,100	-10,414
Net Debt Issued (Repaid)	-	6,935	5,290	866	7,302	7,447
Issuance of Common Stock	-	-	-	-	29	1
Common Dividends Paid	-	-1,164	-3,509	-3,509	-3,463	-3,418
Other Financing Activities	-	-2,566	-2,388	-1,925	-1,892	-1,725
Foreign Exchange Rate Adjustments	-	-61	-42	-258	73	139
Net Cash Flow	-	4,927	123	-3,243	3,357	3,661
Cash Interest Paid	-	2,022	1,874	1,415	1,427	1,356
Cash Income Tax Paid	-	1,431	1,295	1,359	1,469	1,409
Levered Free Cash Flow	-	3,171	2,044	2,019	2,362	2,598
Unlevered Free Cash Flow	-	3,692	2,425	2,294	2,628	2,674
Change in Net Working Capital	-72	155	1,991	2,025	1,764	1,123

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.